Case Report: Neoadjuvant immunotherapy with pembrolizumab alone for bilateral upper tract urothelial carcinoma is a feasible strategy for kidney sparing and avoidance of hemodialysis
Wai-Nga Chan(Chiayi Chang Gung Memorial Hospital), Chen‐Li Cheng(Shanxi University)
Cited by 2